AMOREPACIFIC Ventures

Summary

AMOREPACIFIC Ventures appeared to be the VC, which was created in 1945. The fund was located in Asia if to be more exact in South Korea. AMOREPACIFIC Ventures seemed to be an CVC arrangement as part of the organization. The main office of represented VC is situated in the Seoul.

The typical case for the fund is to invest in rounds with 5 participants. Despite the AMOREPACIFIC Ventures, startups are often financed by Okapi Venture Capital, Domain Associates, Albatross Investment. The meaningful sponsors for the fund in investment in the same round are Wellcome Trust, Vivo Capital, Technology Venture Partners. In the next rounds fund is usually obtained by Domain Associates, Okapi Venture Capital, Mirae Asset Venture Investment.

Among the various public portfolio startups of the fund, we may underline TRIA Beauty, Evofem Biosciences, WayWearable Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Therapeutics, Medical Device.

This AMOREPACIFIC Ventures works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2018. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2012.